Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Zentalis Pharmaceuticals, Inc. (ZNTL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
21.63+0.43 (+2.03%)
At close: 01:00PM EST
22.71 +1.08 (+4.99%)
After hours: 03:49PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/26/2022
Current
9/30/20226/30/20223/31/202212/31/20219/30/2021
Market Cap (intraday)
1.23B1.23B1.60B2.10B3.81B3.00B
Enterprise Value
814.89M825.85M1.36B1.81B3.44B2.75B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/AN/A
Price/Book (mrq)
2.882.615.085.779.7213.46
Enterprise Value/Revenue
N/AN/AN/AN/AN/AN/A
Enterprise Value/EBITDA
-3.66-15.35-21.51-31.43-71.74-43.87

Trading Information

Stock Price History

Beta (5Y Monthly) 1.90
52-Week Change 3-72.13%
S&P500 52-Week Change 3-13.51%
52 Week High 385.95
52 Week Low 317.33
50-Day Moving Average 322.43
200-Day Moving Average 329.78

Share Statistics

Avg Vol (3 month) 3596.72k
Avg Vol (10 day) 3620.4k
Shares Outstanding 557.07M
Implied Shares Outstanding 6N/A
Float 839.77M
% Held by Insiders 17.63%
% Held by Institutions 1104.48%
Shares Short (Oct 30, 2022) 45.96M
Short Ratio (Oct 30, 2022) 412.78
Short % of Float (Oct 30, 2022) 414.24%
Short % of Shares Outstanding (Oct 30, 2022) 410.46%
Shares Short (prior month Sep 29, 2022) 46M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sep 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-29.00%
Return on Equity (ttm)-56.45%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -222.45M
Net Income Avi to Common (ttm)-231.89M
Diluted EPS (ttm)-3.82
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)421.73M
Total Cash Per Share (mrq)7.39
Total Debt (mrq)47.38M
Total Debt/Equity (mrq)11.05
Current Ratio (mrq)8.03
Book Value Per Share (mrq)7.52

Cash Flow Statement

Operating Cash Flow (ttm)-163.44M
Levered Free Cash Flow (ttm)-85.52M
Advertisement
Advertisement